Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: CROSSJECT

Market Cap 11Cr 12Cr 9.69Cr 9.08Cr 17Cr 1.16TCr 17Cr 114.95Cr 45Cr 563.36Cr 46Cr 45Cr 1.95TCr P/E Ratio 2026 *
4.71x
P/E Ratio 2027 * 3.72x
Enterprise Value 8.73Cr 10Cr 8.04Cr 7.53Cr 14Cr 960.5Cr 14Cr 95Cr 37Cr 467.49Cr 38Cr 37Cr 1.62TCr EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.38x
Free-Float
89.86%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.77%-4.20%-20.02%-73.58% 9.16Cr
+0.11%+4.08%+98.89%+37.81% 8.78Cr
Average -1.83%-0.06%+39.43%-17.89% 8.97Cr
Weighted average by Cap. -1.87%-0.15%+38.16%-19.08%

Financials

2026 *2027 *
Net sales 6.08Cr 7.03Cr 5.6Cr 5.25Cr 9.84Cr 669.05Cr 9.98Cr 66Cr 26Cr 325.64Cr 26Cr 26Cr 1.13TCr 4.23Cr 4.89Cr 3.9Cr 3.65Cr 6.84Cr 465.47Cr 6.94Cr 46Cr 18Cr 226.55Cr 18Cr 18Cr 784.1Cr
Net income 2.83Cr 3.27Cr 2.61Cr 2.44Cr 4.58Cr 311.42Cr 4.64Cr 31Cr 12Cr 151.57Cr 12Cr 12Cr 524.59Cr 77.5L 89.64L 71.42L 66.87L 1.25Cr 85Cr 1.27Cr 8.47Cr 3.29Cr 42Cr 3.36Cr 3.29Cr 143.66Cr
Net Debt -1.79Cr -2.07Cr -1.65Cr -1.54Cr -2.9Cr -196.97Cr -2.94Cr -20Cr -7.6Cr -96Cr -7.77Cr -7.6Cr -331.81Cr -4.7Cr -5.44Cr -4.33Cr -4.06Cr -7.6Cr -517.19Cr -7.71Cr -51Cr -20Cr -251.73Cr -20Cr -20Cr -871.22Cr
Logo CROSSJECT
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!